Delivery Order SPE2DB20D7059-SPE2DB25FQHM6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Propranolol ER 80 mg capsules (1,000 count) valued at $1,122.92. This competitive award, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by September 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Propranolol ER 60 mg capsules (100 count) with a ceiling value of $1,571.00. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this order, which will be performed at the company's...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Propranolol ER 60 mg capsules in quantities of 100 units. This firm fixed price delivery order, valued at $4,082.40, represents a non-competitive award and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $3,785.24. This competitive award, issued May 6, 2025, with completion by May 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $6,074.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 160 mg capsules (100-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded and represents a discrete delivery order issued under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a $1,469.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Propranolol ER 160 mg capsules (100-count units). The contract is non-set-aside and represents a competitively awarded delivery order with an ultimate completion date of July 24, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) with a ceiling value of $2,301.91. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) valued at $12,950.60 under a firm fixed-price contract type. The award was made through a competitive process with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the designated place of performance—will fulfill this pharmaceutical delivery order as part of its ongoing...
- The Defense Logistics Agency awarded a $5,312.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Propranolol ER 160 mg capsules (100-count units) on July 11, 2025, with completion targeted for July 14, 2025. This non-competitive delivery order represents a direct fulfillment against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement (SPE2DX) that extends through December 2026. The product...
- The Defense Logistics Agency awarded a $3,603.94 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Propranolol ER 120 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of April 25, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQHM6Delivery Order
The Defense Logistics Agency awarded a $2,467.00 delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 80 mg capsules (100-count units) with a firm fixed price contract structure. This non-set-aside award was executed on May 30, 2025, with an ultimate completion date of June 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical supply requirement fulfilled through the company's existing contracting relationship with DLA. This award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the DLA Medical Supply Chain, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with an extensive portfolio of pharmaceutical products and medical supplies. The company's federal contracting history demonstrates consistent capability in competitively awarded delivery orders across multiple therapeutic domains, supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/30/25 |